Watch Ticker

Annovis Bio, Inc.

Go to Annovis Bio, Inc. Website

$2.68

0.00 (0.00%)

Live

Previous Close

$2.68

Day Range

$0 - $0

Previous Day Range

$2.5 - $2.7

Market Cap

$48.9 million USD

Day Vol.

Previous Day Vol.

136350

Currency

USD

Primary Exchange

New York Stock Exchange

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists o...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - Alzheimer’s Therapeutics Market on Upward Trajectory Across the 7MM During the Forecast Period (2025–2034) Fueled by Drug Development Advances | DelveInsight

The Alzheimer's disease market is expected to grow significantly between 2025-2034, driven by emerging therapies targeting disease mechanisms and improved diagnostic capabilities, with the US market representing approximately 50% of the total market size.

Related tickers: NVO, LLY, BIVI, ANVS.

Read Full Article

N/A - Annovis to Attend AD/PD™ 2025 with Extensive Scientific Program

Annovis Bio, a late-stage clinical drug platform company, will present data from its latest Phase 3 Parkinson's disease and Phase 2/3 Alzheimer's disease studies at the AD/PD™ 2025 conference in Vienna.

Related tickers: ANVS.

Read Full Article

Trending Tickers

Please sign in to view